Skip to menu Skip to content Skip to footer

2025

Conference Publication

Glycaemic Variability Underlies Myocyte Dysfunction and Myocardial Injury Risk in Diabetes

Cao, Y., Redd, M., Outhwaite, J., Mizikovsky, D., Shim, W., Fang, C., Wu, Z., Daygon, D., Stark, T., Palfreyman, R., Chiu, H., Tan, C., Thomas, U., Dragicevic, E., Sng, J., Barrett, H., Dorey, E., Shah, S., Short, K. and Palpant, N. (2025). Glycaemic Variability Underlies Myocyte Dysfunction and Myocardial Injury Risk in Diabetes. 73rd Annual Scientific Meeting ofthe Cardiac Society of Australia and New Zealand, Brisbane, QLD Australia, 14-17 August 2025. Elsevier. doi: 10.1016/j.hlc.2025.06.821

Glycaemic Variability Underlies Myocyte Dysfunction and Myocardial Injury Risk in Diabetes

2024

Conference Publication

Spatially Resolved Atlas of Transplanted Human Cardiac Progenitors Reveals Post-Infarct Cardiac Regeneration and Cellular Maturation

Adusumalli, Swarnaseetha, Lim, Samantha, Ren, Vincent, Chong, Li Yen, Tan, Clarissa, Tham, Roy, Leong, Kye Siong, Cheng, Min En, Lei, Ye, Wang, Yibin, Petretto, Enrico, Tryggvason, Karl and Yap, Lynn (2024). Spatially Resolved Atlas of Transplanted Human Cardiac Progenitors Reveals Post-Infarct Cardiac Regeneration and Cellular Maturation. ISHR-SEA 2024 Meeting, Singapore, 3 - 4 October 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jmccpl.2024.100134

Spatially Resolved Atlas of Transplanted Human Cardiac Progenitors Reveals Post-Infarct Cardiac Regeneration and Cellular Maturation

2024

Conference Publication

Trastuzumab-Induced Cardiotoxicity Involves Antibody Dependent Cell Cytotoxicity (ADCC)

Griffiths, L., Ho, U., Burt, K., Watson, S., Patel, K., Bradford, J., Tan, C., Bhavsar, C., Palpant, N., Souza-Fonseca-Guimaraes, F., Wu, S., Reichelt, M. and Thomas, W. (2024). Trastuzumab-Induced Cardiotoxicity Involves Antibody Dependent Cell Cytotoxicity (ADCC). 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Perth, WA Australia, 1-4 August 2024. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2024.06.397

Trastuzumab-Induced Cardiotoxicity Involves Antibody Dependent Cell Cytotoxicity (ADCC)

2024

Conference Publication

Preclinical models of Glycaemic variability recapitulate Clinical Cardiovascular outcomes in Diabetes

Cao, Y., Redd, M., Outhwaite, J., Shim, W., Fang, C., Negi, S., Shen, S., Mizikovsky, D., Chiu, H., Tan, C., Thomas, U., Dragicevic, E., Sng, J., Short, K. and Palpant, N. (2024). Preclinical models of Glycaemic variability recapitulate Clinical Cardiovascular outcomes in Diabetes. 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Perth, WA Australia, 1-4 August 2024. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2024.06.332

Preclinical models of Glycaemic variability recapitulate Clinical Cardiovascular outcomes in Diabetes

2024

Conference Publication

Dissecting the Role of Hopx Variants in Cardiac Remodelling and Dysfunction

Hanna, A., Negi, S., Outhwaite, J., Cheng, T., Tan, C., Chen, J., Fatkin, D., Haas, J. and Palpant, N. (2024). Dissecting the Role of Hopx Variants in Cardiac Remodelling and Dysfunction. International Clinical Cardiovascular Genetics Conference 2024, Brisbane, QLD Australia, 8-10 May 2024. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2024.04.189

Dissecting the Role of Hopx Variants in Cardiac Remodelling and Dysfunction

2024

Conference Publication

Preserving clinical efficacy of mesenchymal stem cells with glycosaminoglycan additives

Shokoohmand, A., Srinivasan, A., Ling, L., Silva, F. Rodrigues de Oliveira, Eio, M.Y., Lu, X., Loberas, M., Tao, K., Tan, C., Nurcombe, V., Hui, J., Smith, R. and Cool, S. (2024). Preserving clinical efficacy of mesenchymal stem cells with glycosaminoglycan additives. 30th Annual ISCT Meeting, Vancouver, BC, Canada, 29 May - 1 June 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jcyt.2024.03.116

Preserving clinical efficacy of mesenchymal stem cells with glycosaminoglycan additives

2019

Conference Publication

Biomimicry of glycosaminoglycans in the bone marrow microenvironment favour the expansion of highly potent human mesenchymal stem cells

Ling, L., Ren, X., Hassan, A. Binte Mohd, Mah, S., Smith, R. A., Tan, C., van Wijnen, A., Raghunath, M., Nurcombe, V., Hui, J. and Cool, S. (2019). Biomimicry of glycosaminoglycans in the bone marrow microenvironment favour the expansion of highly potent human mesenchymal stem cells. ISCT 2019, Melbourne, VIC Australia, 29 May - 1 June 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jcyt.2019.03.463

Biomimicry of glycosaminoglycans in the bone marrow microenvironment favour the expansion of highly potent human mesenchymal stem cells